This inventor holds 7 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignees: Oncothyreon Inc., Biomira, Inc.. Active years: 1991-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1991-2013
Title: R Rao Koganty: Innovator in Vaccine Development
Introduction
R Rao Koganty is a prominent inventor based in Edmonton, Canada, known for his significant contributions to the field of immunology. With a total of seven patents to his name, Koganty has made remarkable strides in vaccine development, particularly in modulating immune responses.
Latest Patents
Among his latest innovations is a vaccine designed for modulating between T1 and T2 immune responses. This invention provides liposomal vaccines containing immunogenic lipopeptides that are capable of modulating the humoral and cellular immune responses in vivo. This groundbreaking work has the potential to enhance vaccine efficacy and improve patient outcomes.
Career Highlights
Throughout his career, Koganty has worked with notable companies such as Oncothyreon Inc. and Biomira, Inc. His experience in these organizations has allowed him to refine his expertise in vaccine technology and immunotherapy.
Collaborations
Koganty has collaborated with esteemed colleagues, including Wladyslaw A Budzynski and Mark J Krantz. These partnerships have fostered a collaborative environment that has led to innovative solutions in the field of immunology.
Conclusion
R Rao Koganty stands out as a key figure in vaccine innovation, with a focus on enhancing immune response modulation. His contributions continue to shape the future of immunotherapy and vaccine development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile